Announcements Trials
Browse Landscape

Phase

Phase NA 2

Status

Terminated 1Completed 1

Sponsor Class

OTHER 2

Study Type

Observational 2Interventional 2

Sponsor

Cancer Type

Dermatologic 2

Conditions

Melanoma 2Skin Neoplasms 1Nevus, Pigmented 1Margins of Excision 1Disease 1Carcinoma, Basal Cell 1

Interventions

pembrolizumab 287Nivolumab 258Ipilimumab 236aldesleukin 134Cyclophosphamide 134Interleukin-2 104Temozolomide 75Dacarbazine 74trametinib 70Vemurafenib 69fludarabine 67dabrafenib 65fludarabine phosphate 61sargramostim 44binimetinib 44Radiosurgery 44Biopsy 43Paclitaxel 42Bevacizumab 42incomplete Freund's adjuvant 39encorafenib 37Radiotherapy 36Cisplatin 36CTLA-4 Antigen 36atezolizumab 35Carboplatin 35cobimetinib 32Magnetic Resonance Spectroscopy 32Introns 30Specimen Handling 29

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

2 trials
RecentStart dateEnrollment
Interventional × Melanoma × Dermoscopy × Clear all
NCT03699995 2026-04-08

MoleMapper, Visiomed, and Confocal Microscopy in Screening Participants for Melanoma

OHSU Knight Cancer Institute

Phase NA Terminated
17 enrolled
Dermatologic

Melanoma, Nevus, Pigmented

NCT04789421 2021-03-09

NET-DAM

Azienda Ospedaliero-Universitaria di Modena

Phase NA Completed
3,248 enrolled
Dermatologic

Disease, Melanoma

Data powered by HemOnc (CC BY 4.0) Colophon âš¡